kentucky glp-1 side effect lawsuit Louisville patients warn about dangers of weight loss drugs and life-changing effects Ozempic GLP-1 Lawsuit & Gastroparesis

10.1016/j.bbrc.2014.09.096 103

Work with a provider who offers real medical oversight

Patients should understand that off-label microdosing lacks the evidence base that supports FDA-approved dosing, and outcomes may differ significantly from those observed in clinical trials

Methods: Five different cases of women with lipedema and insulin resistance, treated with Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and once-weekly exenatide, in association or not with lifestyle changes (diet or physical activity) for 3 to 6 months are described

Despite the side effects and murky insurance coverage, GLP-1s are becoming more common weight loss interventions

This level of effectiveness has revolutionized weight management, offering hope to millions struggling with obesity and its associated health risks